Fagron Genomics Review: What You’re Not Being Told About Their DNA Tests

Overview

1. Products: Offers five genetic tests: NutriGen, TrichoTest™, TeloTest, AcneTest, and Sport Test.
2. Cost: Pricing is not listed online and requires direct contact with the company.
3. Reports: PDF and interactive reports are available through a digital platform.
4. Raw data access: Raw genetic data is not accessible to users.
5. Privacy: No publicly available information on data privacy or security standards.
6. Alternatives: OmicsEdge and PromicsEdge provide broader testing, validated predictions, and multiomic analysis.

Fagron Genomics Pros and Cons

Pros

• Offers multiple DNA test panels tailored to specific health areas (e.g., acne, aging, weight loss, athletic performance)
• Multilingual report delivery and international availability in 35+ countries
• Simple sample collection process using buccal swabs

Cons

• No use of polygenic risk scoring (PRS), limiting predictive power
• Lack of transparency around scientific methodology, variant selection, or evidence grading
• No published validation studies or peer-reviewed research
• Generic, static reports without dynamic risk assessment or integration of lab data
• Weak privacy transparency; unclear HIPAA or GDPR compliance
• No raw data access or download options for users or practitioners
• Absence of customer reviews or user testimonials on official platforms
• Poor employee feedback and internal credibility concerns based on public job review sites

About Fagron Genomics

Fagron Genomics is a division of Fagron, a pharmaceutical company founded in the Netherlands in 1990. The company specializes in pharmaceutical compounding and sterile outsourcing services and operates in over 35 countries. Fagron Genomics offers DNA testing services aimed at supporting personalized treatment through healthcare providers. The company is headquartered in Rotterdam, South Holland.

Review of Fagron Genomics Products & Services

Fagron Genomics offers direct-to-provider genetic testing services designed to support personalized treatment decisions.

Their process follows a standard flow: providers order a DNA collection kit, collect the patient’s buccal swab sample, send it to the Fagron Genomics lab, and receive results through an online platform. Reports are available in multiple languages and formats, including PDF and interactive versions.

Their main products include:

• NutriGen: Focused on weight loss and lifestyle habits, providing guidance on food intake and supplement use.
• TrichoTest™: A pharmacogenetic test designed to guide treatment decisions for various forms of hair loss.
• TeloTest: Evaluates biological age by assessing telomere-related markers and suggests anti-aging formulations.
• AcneTest: Supports personalized acne treatments based on genetic predisposition.
• Sport Test: Offers genetic insights for athletes to improve performance and minimize injury risk.

While Fagron emphasizes “clinical genetic interpretation” and actionable results, there is no evidence of published validation, peer-reviewed research, or external audits of their methods.

Their website highlights convenience and multilingual support but does not disclose whether results are adjusted for ancestry, or if the algorithms used have undergone scientific peer review.

Additionally, the reports do not incorporate lab results, symptom tracking, or health history, which are now standard for personalized and predictive health applications.

Review of Fagron Genomics DNA Report

The Fagron NutriGen DNA report claims to offer personalized nutrition, supplementation, and weight loss guidance based on genetics, analyzing over 100 SNPs across various health categories. However, a closer look reveals several limitations that may significantly reduce the report’s utility for both practitioners and consumers.

The report is primarily based on single-gene analysis, with no evidence of polygenic risk scoring (PRS), which is now considered the gold standard for evaluating genetic predispositions.

Without PRS, the report lacks the predictive power needed to make truly personalized or reliable health assessments. Grouping SNPs without weighing their individual or combined influence means the results risk oversimplifying complex genetic traits.

Although the test spans 15 broad macrocategories, it treats each gene and variant in isolation. The information is largely descriptive, providing generic labels like “normal metabolism” or “ensure daily recommended intake,” but lacking detailed explanations or actionable context.

The supplement and food list sections appear extensive, yet the logic behind the recommendations is unclear and not transparently linked to the genetic results. Furthermore, there are no scientific references or citations provided in the report to support the recommendations, which limits clinical credibility.

The most concerning limitation is the absence of any personalized recommendations or interpretation tools. There is also no mechanism to update or refine results with lab data, lifestyle inputs, or follow-up testing, meaning the reports remain static over time.

Without gene-gene interaction analysis, environmental context, or individualized guidance, the report reads more like a broad template than a genuinely tailored health tool.

Lastly, while the visual presentation is polished, the lack of scientific depth, transparency, and modern genetic analysis tools (like PRS or dynamic scoring) makes the Fagron NutriGen report a weak option for users seeking high-quality, evidence-based genetic insights.

Cost of Fagron Genomics

Fagron Genomics does not publish general pricing on its official site and instead requires practitioners to reach out via email or through their platform to place orders or obtain quotes.

Health Recommendations from Fagron Genomics

The Fagron Genomics reports offer general advice based on single gene variants, but fall short of delivering personalized or predictive health recommendations.

While the reports touch on areas like diet, exercise, nutrient metabolism, and supplementation, the guidance is not dynamically generated or adjusted based on risk level, lifestyle data, or clinical history.

Most notably, Fagron does not use polygenic risk scoring (PRS), a widely accepted method that aggregates the influence of multiple genetic variants to better predict complex traits and health outcomes.

Without PRS, any recommendations provided cannot be considered predictive, especially for multifactorial traits like obesity, cardiovascular risk, or athletic performance. Instead, results are based on isolated SNPs, which individually have small effect sizes and limited clinical utility when used alone.

Although Fagron includes pre-written suggestions, such as diet types or supplement formulas, these are template-based and not tailored to the user’s overall genetic profile.

There’s no prioritization, confidence scoring, or indication of which actions might offer the most benefit. This makes the recommendations feel generic and better suited as starting points for discussion rather than actionable guidance.

Overall, the health recommendations lack depth, scientific rigor, and true personalization, which limits their usefulness for individuals or practitioners seeking clinically meaningful insights.

Fagron Genomics Privacy & Security

Fagron Genomics does not provide detailed privacy or data protection policies directly on its main website. While it mentions that reports are delivered securely through a digital platform, there is no clear public documentation outlining how genetic data is stored, shared, or protected.

There is also no mention of whether Fagron Genomics complies with common data protection regulations such as GDPR (General Data Protection Regulation) or HIPAA (Health Insurance Portability and Accountability Act) for handling sensitive health information.

Without transparent privacy documentation or user agreements available online, it’s difficult to assess how Fagron Genomics handles consent, third-party data access, or long-term data retention.

Fagron Genomics Reviews

Fagron Genomics lacks both customer reviews and public case studies on its own site, offering no clear insight into user satisfaction or real-world outcomes.

At the time of writing, employee feedback from Indeed underscores broader organizational concerns: Fagron holds a 2.6/5 overall rating (based on 82 reviews), with particularly low scores in job security, management, and workplace culture. While flexibility is noted as a positive, most comments describe a high-turnover environment, poor internal communication, and a lack of trust in leadership.

On Reddit, user skepticism extends to their genetic testing products. A widely viewed post on their TrichoTest™ drew criticism for lacking a scientific basis. One commenter stated that “you cannot determine response from these SNPs” and called the test “basically a scam,” while alleging the genetic variants tested are “completely random.”

The absence of peer or user validation, combined with reports of unsettling workplace dynamics, raises concerns about both the credibility of Fagron Genomics’ services and its organizational stability.

Alternatives to Fagron Genomics

While Fagron Genomics offers several genetic panels for specific use cases like acne, aging, weight loss, and athletic performance, it lacks the depth and scientific rigor found in more advanced solutions.

OmicsEdge and PromicsEdge (powered by OmicsEdge) stand out as significantly more robust alternatives for health practitioners looking for cutting-edge, validated, and comprehensive solutions in personalized health.

These platforms use ancestry-adjusted polygenic risk scores, published in a Nature journal, to deliver the most accurate predictions of conditions and traits available in the industry. In contrast to limited single-gene testing, their approach analyzes over 200 million variants, applying AI to assess millions per report and generate data-driven health insights.

OmicsEdge and PromicsEdge go beyond genetics alone. They offer advanced health recommendations by integrating multiple data types, including genetics, lab results, symptoms, and existing health conditions, delivering truly multiomic analysis. This enables practitioners to provide highly tailored guidance that adapts to the individual in real time.

Their credibility is further backed by six published validation studies in top-tier journals, and they maintain strict HIPAA and GDPR compliance to ensure data privacy and security. Reports are available for 1,500+ topics and continue to expand, offering an unmatched level of comprehensiveness and customization for both consumers and practitioners.

If you’re seeking a more scientifically advanced and integrative approach than what Fagron Genomics currently offers, OmicsEdge and PromicsEdge provide a compelling and validated alternative.

See a sample report from OmicsEdge or Fagron Genomics to compare for yourself.

Fagron Genomics Review Summary

Fagron Genomics offers a polished consumer-facing product with multilingual accessibility and a wide geographical reach, but the substance behind the reports falls short for serious precision health applications.

The absence of polygenic risk scoring, lack of lab and symptom integration, and no peer-reviewed validation severely limit the predictive value and scientific credibility of their tests. Without published studies, transparent methodology, or robust privacy policies, practitioners and consumers are left to take the company’s claims on trust alone.

For those seeking evidence-backed, multiomic, and truly personalized insights, solutions like OmicsEdge and PromicsEdge provide a far more advanced, validated, and secure alternative.